Clinical trials
Phase 1/2 Carcinoma, Medullary trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2007 | 1 |
| 2009 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2019 | 2 |
| 2021 | 1 |
| 2023 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Terminated | 4 |
| Unknown status | 3 |
| Active, not recruiting | 2 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 2 |
| National Cancer Institute (NCI) | 2 |
| AbbVie | 1 |
| Garden State Cancer Center at the Center for Molecular Medicine and Immunology | 1 |
| Genzyme, a Sanofi Company | 1 |
| Hoffmann-La Roche | 1 |
| M.D. Anderson Cancer Center | 1 |
| Nantes University Hospital | 1 |
| Salient Pharmaceuticals Incorporated | 1 |
| Shouyao Holdings (Beijing) Co. LTD | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Medullary | 15 |
| Carcinoma, Non-Small-Cell Lung | 6 |
| Thyroid Neoplasms | 6 |
| Neoplasms | 5 |
| Head and Neck Neoplasms | 4 |
| Lung Neoplasms | 4 |
| Thyroid Diseases | 4 |
| Bronchial Neoplasms | 3 |
| Carcinoma, Bronchogenic | 3 |
| Colonic Neoplasms | 3 |
Trials
Showing 51 to 15 of 15. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.